Clinical Trial Update: Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sirolimus with cyclophosphamide in metastatic or unresectable myxoid liposarcoma and chondrosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conventional Chondrosarcoma
• Dedifferentiated Chondrosarcoma
• Mesenchymal Chondrosarcoma
• Myxoid Liposarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Conventional Chondrosarcoma, Myxoid Liposarcoma | Phase 2 | Status: COMPLETED